First Generic of Once-Daily GLP-1 Injection Approved for Diabetes
The FDA has approved the first generic form of liraglutide (Victoza), a once-daily injectable for improving glycemic control in patients ages 10 and older with
The FDA has approved the first generic form of liraglutide (Victoza), a once-daily injectable for improving glycemic control in patients ages 10 and older with
MASH is a form of non-alcoholic liver disease. Credit: SEBASTIAN KAULITZKI / SCIENCE PHOTO LIBRARY via Getty Images. Eli Lilly is paying up to $630m
California biotech Alto Neuroscience has filed to go public as it runs two Phase IIb trials for its two lead major depressive disorder drug candidates.